Literature DB >> 2341386

An expression system for human apolipoprotein B100 in a rat hepatoma cell line.

B D Blackhart1, Z M Yao, B J McCarthy.   

Abstract

We have designed an in vitro expression system for human apolipoprotein (apo) B. A full-length human apoB minigene was constructed from cDNA and genomic apoB clones and inserted into a vector where its expression was directed by the cytomegalovirus promoter. The apoB minigene was expressed in a rat hepatoma cell line, McA-RH7777. Human apoB100, which is the ligand for the low density lipoprotein receptor, was secreted in low density lipoprotein or very low density lipoprotein particles, depending on the composition of the medium. A protein with the mobility of apoB48, a structurally related protein involved in cholesterol metabolism, was also produced from the human apoB minigene. This in vitro expression system for human apoB will enable investigators to identify which domains of this protein are involved in processes such as lipoprotein assembly and secretion. This system should also allow investigators to identify definitively the domain in apoB that enables the protein to bind to the low density lipoprotein receptor.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2341386

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  Rat carboxylesterase ES-4 enzyme functions as a major hepatic neutral cholesteryl ester hydrolase.

Authors:  Saj Parathath; Snjezana Dogan; Victor A Joaquin; Snigdha Ghosh; Liang Guo; Ginny L Weibel; George H Rothblat; Earl H Harrison; Edward A Fisher
Journal:  J Biol Chem       Date:  2011-09-20       Impact factor: 5.157

2.  Secretion of triacylglycerol-poor VLDL particles from McA-RH7777 cells expressing human hepatic lipase.

Authors:  Michelle Bamji-Mirza; Meenakshi Sundaram; Shumei Zhong; Erik F Yao; Robin J Parks; Zemin Yao
Journal:  J Lipid Res       Date:  2010-12-27       Impact factor: 5.922

3.  Palmitoylation of apolipoprotein B is required for proper intracellular sorting and transport of cholesteroyl esters and triglycerides.

Authors:  Y Zhao; J B McCabe; J Vance; L G Berthiaume
Journal:  Mol Biol Cell       Date:  2000-02       Impact factor: 4.138

4.  Measurement of apolipoprotein B in various cell lines: correlation between intracellular levels and rates of secretion.

Authors:  A Bakillah; Z Zhou; J Luchoomun; M M Hussain
Journal:  Lipids       Date:  1997-10       Impact factor: 1.880

5.  Mutagenesis of the human apolipoprotein B gene in a yeast artificial chromosome reveals the site of attachment for apolipoprotein(a).

Authors:  S P McCormick; J K Ng; S Taylor; L M Flynn; R E Hammer; S G Young
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-24       Impact factor: 11.205

6.  Modification of the apolipoprotein B gene in HepG2 cells by gene targeting.

Authors:  R V Farese; L M Flynn; S G Young
Journal:  J Clin Invest       Date:  1992-07       Impact factor: 14.808

7.  Expression, secretion, and lipid-binding characterization of the N-terminal 17% of apolipoprotein B.

Authors:  H Herscovitz; M Hadzopoulou-Cladaras; M T Walsh; C Cladaras; V I Zannis; D M Small
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-15       Impact factor: 11.205

8.  Model systems for studying the assembly, trafficking, and secretion of apoB lipoproteins using fluorescent fusion proteins.

Authors:  Meghan T Walsh; Oni M Celestin; James H Thierer; Sujith Rajan; Steven A Farber; M Mahmood Hussain
Journal:  J Lipid Res       Date:  2019-12-30       Impact factor: 5.922

9.  Sequences containing the second-intron enhancer are essential for transcription of the human apolipoprotein B gene in the livers of transgenic mice.

Authors:  A R Brooks; B P Nagy; S Taylor; W S Simonet; J M Taylor; B Levy-Wilson
Journal:  Mol Cell Biol       Date:  1994-04       Impact factor: 4.272

10.  Expression of human apolipoprotein B and assembly of lipoprotein(a) in transgenic mice.

Authors:  M J Callow; L J Stoltzfus; R M Lawn; E M Rubin
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.